BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He J, Xiao B, Li X, He Y, Li L, Sun Z. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL. Biomed Res Int 2019;2019:2732057. [PMID: 31976317 DOI: 10.1155/2019/2732057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Zong Y, Tang J, Ke R, Lv L, Wu M, Lu J. miR-369-3p serves as prognostic factor and regulates cancer progression of hepatocellular carcinoma. Per Med 2021;18:375-88. [PMID: 33792408 DOI: 10.2217/pme-2020-0012] [Reference Citation Analysis]
2 Lin XM, Wang ZJ, Lin YX, Chen H. Decreased exosome-delivered miR-486-5p is responsible for the peritoneal metastasis of gastric cancer cells by promoting EMT progress. World J Surg Oncol 2021;19:312. [PMID: 34686196 DOI: 10.1186/s12957-021-02381-5] [Reference Citation Analysis]
3 Lei X, Yang M, Xiao Z, Zhang H, Tan S. circTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis. Open Life Sci 2021;16:362-74. [PMID: 33954256 DOI: 10.1515/biol-2021-0041] [Reference Citation Analysis]
4 Chen S, Zhang Y, Ding X, Li W. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma. Front Genet 2022;13:838869. [PMID: 35386284 DOI: 10.3389/fgene.2022.838869] [Reference Citation Analysis]
5 Ju J, Han W, Shi C. Long non-coding RNA (lncRNA) plasmacytoma variant translocation 1 gene (PVT1) modulates the proliferation and apoptosis of acute lymphoblastic leukemia cells by sponging miR-486-5p. Bioengineered 2022;13:4587-97. [DOI: 10.1080/21655979.2022.2031405] [Reference Citation Analysis]
6 Ma N, Li S, Lin C, Cheng X, Meng Z. Mesenchymal stem cell conditioned medium attenuates oxidative stress injury in hepatocytes partly by regulating the miR-486-5p/PIM1 axis and the TGF-β/Smad pathway. Bioengineered 2021;12:6434-47. [PMID: 34519263 DOI: 10.1080/21655979.2021.1972196] [Reference Citation Analysis]
7 de Bruyn DP, Beasley AB, Verdijk RM, van Poppelen NM, Paridaens D, de Keizer ROB, Naus NC, Gray ES, de Klein A, Brosens E, Kiliç E. Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines 2022;10:506. [PMID: 35203714 DOI: 10.3390/biomedicines10020506] [Reference Citation Analysis]
8 Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, Yonemori M, Yamada Y, Tatarano S, Nakagawa M, Enokida H. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. BMC Cancer 2021;21:48. [PMID: 33430801 DOI: 10.1186/s12885-020-07717-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]